Cargando…

High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression

The circulating microRNA (miRNA) profile has been widely used for identifying potential biomarkers against viral infections. However, data on circulating microRNA expression patterns in dengue patients are scanty. Considering the impact of severity caused by dengue infection, circulating miRNA profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Jaya, Bandyopadhyay, Bhaswati, Pandey, Abhay Deep, Ramachandran, V. G., Das, Shukla, Sood, Vikas, Banerjee, Arup, Vrati, Sudhanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498686/
https://www.ncbi.nlm.nih.gov/pubmed/32934118
http://dx.doi.org/10.1128/mSystems.00724-20
_version_ 1783583566000553984
author Saini, Jaya
Bandyopadhyay, Bhaswati
Pandey, Abhay Deep
Ramachandran, V. G.
Das, Shukla
Sood, Vikas
Banerjee, Arup
Vrati, Sudhanshu
author_facet Saini, Jaya
Bandyopadhyay, Bhaswati
Pandey, Abhay Deep
Ramachandran, V. G.
Das, Shukla
Sood, Vikas
Banerjee, Arup
Vrati, Sudhanshu
author_sort Saini, Jaya
collection PubMed
description The circulating microRNA (miRNA) profile has been widely used for identifying potential biomarkers against viral infections. However, data on circulating microRNA expression patterns in dengue patients are scanty. Considering the impact of severity caused by dengue infection, circulating miRNA profiles in plasma of dengue patients may prove to be valuable for developing early prognostic markers for the disease severity. Here, we described an in-depth analytical study of small RNA sequencing data obtained from the plasma of 39 dengue patients. Integrating bioinformatics and in vitro studies, we identified differentially expressed miRNAs (DEMs) (log(2) fold change ≥1.5, P < 0.05) associated with dengue disease progression. In comparing miRNA expression pattern with the follow-up samples, nine miRNAs were found to exhibit an altered expression that could distinguish between severe dengue and the convalescent patients. To understand the abundance and specificity of the DEMs in the context of dengue infection and disease progression, eight top-hit DEMs were further validated in the dengue virus-infected cell lines as well as in the patient’s plasma and peripheral blood mononuclear cells (PBMCs) using the quantitative reverse transcription-PCR (qRT‐PCR) method. Importantly, receiver operating curve analysis further confirmed that the plasma expression pattern of hsa-miR-122-5p could differentiate between different stages of dengue infection (area under the concentration-time curve [AUC] = 0.792), and dengue-negative patients with other febrile illnesses (AUC = 0.984). The in silico analysis of DEM target genes suggested an enrichment of the pathways associated with metabolism and inflammation. Our study gives a global view of miRNA expression in the plasma from dengue patients and provides a precious resource of candidate miRNAs involved in dengue infection and disease progression. IMPORTANCE Dengue virus (DENV) infection usually causes dengue fever (DF) with flu-like illness affecting infants, young children, and adults. The DF occasionally evolves into a potentially lethal complication called dengue severe (DS) leading to a rapid fall in platelet count along with plasma leakage, fluid accumulation, respiratory distress, and severe bleeding. The diverse clinical spectrum of dengue disease, as well as its significant similarity to other febrile viral illnesses, makes early identification more challenging in this high-risk group. microRNAs (miRNAs) are small (∼19 to 21 nucleotides [nt] in length), noncoding RNAs, extremely stable and easily detectable in the plasma; thus, they have potential as biomarkers for diagnosing and monitoring human diseases. This study provides a comprehensive analysis of miRNAs circulating in plasma of dengue virus-infected patients and identifies the miRNA signatures that have biomarker potential for dengue infection and disease progression.
format Online
Article
Text
id pubmed-7498686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-74986862020-10-01 High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression Saini, Jaya Bandyopadhyay, Bhaswati Pandey, Abhay Deep Ramachandran, V. G. Das, Shukla Sood, Vikas Banerjee, Arup Vrati, Sudhanshu mSystems Research Article The circulating microRNA (miRNA) profile has been widely used for identifying potential biomarkers against viral infections. However, data on circulating microRNA expression patterns in dengue patients are scanty. Considering the impact of severity caused by dengue infection, circulating miRNA profiles in plasma of dengue patients may prove to be valuable for developing early prognostic markers for the disease severity. Here, we described an in-depth analytical study of small RNA sequencing data obtained from the plasma of 39 dengue patients. Integrating bioinformatics and in vitro studies, we identified differentially expressed miRNAs (DEMs) (log(2) fold change ≥1.5, P < 0.05) associated with dengue disease progression. In comparing miRNA expression pattern with the follow-up samples, nine miRNAs were found to exhibit an altered expression that could distinguish between severe dengue and the convalescent patients. To understand the abundance and specificity of the DEMs in the context of dengue infection and disease progression, eight top-hit DEMs were further validated in the dengue virus-infected cell lines as well as in the patient’s plasma and peripheral blood mononuclear cells (PBMCs) using the quantitative reverse transcription-PCR (qRT‐PCR) method. Importantly, receiver operating curve analysis further confirmed that the plasma expression pattern of hsa-miR-122-5p could differentiate between different stages of dengue infection (area under the concentration-time curve [AUC] = 0.792), and dengue-negative patients with other febrile illnesses (AUC = 0.984). The in silico analysis of DEM target genes suggested an enrichment of the pathways associated with metabolism and inflammation. Our study gives a global view of miRNA expression in the plasma from dengue patients and provides a precious resource of candidate miRNAs involved in dengue infection and disease progression. IMPORTANCE Dengue virus (DENV) infection usually causes dengue fever (DF) with flu-like illness affecting infants, young children, and adults. The DF occasionally evolves into a potentially lethal complication called dengue severe (DS) leading to a rapid fall in platelet count along with plasma leakage, fluid accumulation, respiratory distress, and severe bleeding. The diverse clinical spectrum of dengue disease, as well as its significant similarity to other febrile viral illnesses, makes early identification more challenging in this high-risk group. microRNAs (miRNAs) are small (∼19 to 21 nucleotides [nt] in length), noncoding RNAs, extremely stable and easily detectable in the plasma; thus, they have potential as biomarkers for diagnosing and monitoring human diseases. This study provides a comprehensive analysis of miRNAs circulating in plasma of dengue virus-infected patients and identifies the miRNA signatures that have biomarker potential for dengue infection and disease progression. American Society for Microbiology 2020-09-15 /pmc/articles/PMC7498686/ /pubmed/32934118 http://dx.doi.org/10.1128/mSystems.00724-20 Text en Copyright © 2020 Saini et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Saini, Jaya
Bandyopadhyay, Bhaswati
Pandey, Abhay Deep
Ramachandran, V. G.
Das, Shukla
Sood, Vikas
Banerjee, Arup
Vrati, Sudhanshu
High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title_full High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title_fullStr High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title_full_unstemmed High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title_short High-Throughput RNA Sequencing Analysis of Plasma Samples Reveals Circulating microRNA Signatures with Biomarker Potential in Dengue Disease Progression
title_sort high-throughput rna sequencing analysis of plasma samples reveals circulating microrna signatures with biomarker potential in dengue disease progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498686/
https://www.ncbi.nlm.nih.gov/pubmed/32934118
http://dx.doi.org/10.1128/mSystems.00724-20
work_keys_str_mv AT sainijaya highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT bandyopadhyaybhaswati highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT pandeyabhaydeep highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT ramachandranvg highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT dasshukla highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT soodvikas highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT banerjeearup highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression
AT vratisudhanshu highthroughputrnasequencinganalysisofplasmasamplesrevealscirculatingmicrornasignatureswithbiomarkerpotentialindenguediseaseprogression